Basking Biosciences
Cary, US · Founded 2019 · Delaware corporation · 4 known investors
Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease. The company focuses on stroke and cardiovascular applications.
Founders & leadership
SN
Shahid NimjeeinCo-founder, Chief Scientific Officer and Stroke Clinical Lead
BS
Bruce SullengerCo-founder
HC
Hannah ChangDirector
JO
Julia OwensExecutive Officer, Director, Promoter
AA
Aiden AcevesDirector
DA
David AdairDirector
TN
Thomas NeedhamDirector
RH
Ryan HelonDirector
DM
Dan MyersDirector
RS
Richard SheaExecutive Officer, Director, Promoter
SG
Steve GillisDirector
AN
Ari NowacekDirector
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$55MraisedOct 2025 · 11 investors · BiotechnologyRule 506(b)
▶$55MraisedOct 2025 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hannah ChangDirector
- Julia OwensExecutive Officer, Director, Promoter
- Aiden AcevesDirector
- David AdairDirector
- Steve GillisDirector
- Ari NowacekDirector
- Shahid NimjeeDirector
- Thomas NeedhamDirector
- Offering amount
- $55M
- Amount sold
- $55M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedSep 2020 · 6 investors · BiotechnologyRule 506(b)
▶$1.9MraisedSep 2020 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ryan HelonDirector
- Thomas NeedhamDirector
- Dan MyersDirector
- Richard SheaExecutive Officer, Director, Promoter
- Shahid NimjeeDirector
- Bruce SullengerDirector
- Offering amount
- $7M
- Amount sold
- $1.9M
- First sale
- Aug 2020
- Incorporated
- Corporation, North Carolina, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Basking Biosciences | Investment | Insight Partnersinsightpartners.com · 2026
- Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officerprnewswire.com · 2025
- Ohio State spinoff Basking Biosciences raises $55 million to test stroke treatmentohiotechnews.com · 2024
- Fast-acting reversible stroke treatment developer Basking Biosciences raises $55M - Columbus Business Firstbizjournals.com · 2024
- Basking Biosciences Closes $55M Financingfinsmes.com · 2024
- Triangle-based Basking Biosciences raises $27.5 million - Business North Carolinabusinessnc.com · 2023